Direct oral anticoagulants for stroke prevention in atrial fibrillation: treatment outcomes and dosing in special populations.
CONCLUSIONS: Overall, results of secondary analyses indicate that the recommended dosing strategy for each of the DOACs produces a consistent anticoagulant effect across a diverse patient population, including those at increased risk of stroke or bleeding.
PMID: 30081727 [PubMed - in process]
Source: Adv Data - Category: Epidemiology Authors: Stacy ZA, Richter SK Tags: Ther Adv Cardiovasc Dis Source Type: research
More News: Atrial Fibrillation | Bleeding | Cardiology | Clinical Trials | Coumadin | Diabetes | Endocrinology | Epidemiology | Heart | Heart Attack | Heart Failure | Hypertension | Peripheral Vascular Disease (PVD) | Pradaxa | Stroke | Warfarin